BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 10
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (84)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF7
HTML52
Figures (1-1)6
Tables (1-3)6
 Sum=71
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse0
Download0
 Sum=0
Oct 24, 2025 (publication date) through Oct 27, 2025
Times Cited of This Article
  • Times Cited  (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
Copyright ©The Author(s) 2025.
World J Clin Oncol. Oct 24, 2025; 16(10): 111028
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.111028
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Major dysregulated gene expressions contributing in histopathological progression of gallbladder cancer. VEGF: Vascular endothelial growth factor; PD-L1: Programmed death-ligand 1.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345